logo

Lung Cancer Surgery Market Size (2024 - 2029)

The market size for lung cancer surgery is anticipated to grow due to the increasing incidence of lung cancer, which is significantly influenced by rising air pollution levels. This environmental factor is a major contributor to respiratory diseases, including lung cancer, thereby impacting the demand for surgical interventions. The prevalence of ultra-fine particulate matter, particularly in highly polluted regions, underscores the link between pollution and the growing need for lung cancer surgeries, shaping the market dynamics.

Home Market Analysis Healthcare Research Medical Devices Research Surgical Devices Research Specialty Surgical Devices Research Lung Cancer Surgery Market Market Size

Market Size of Lung Cancer Surgery Industry

Lung Cancer Surgery Market
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 7.00 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Lung Cancer Surgery Market Analysis

Rising air pollution and people getting affected by it are one of the prime factors responsible for the growth of the market for lung cancer surgery. As per an article by the Vital Strategies Environmental Health Division staff, 2018, while most of the 4.2 million premature deaths linked to air pollution are due to heart disease and strokes, around 1.7 million deaths are from lung cancer and other respiratory diseases globally. According to the WHO database, levels of ultra-fine particles of less than 2.5 microns are highest in India, which has 16 of the world's 30 most polluted cities. Thus, a rise in air pollution is, primarily, driving the lung cancer rate, and hence the studied market is expected to be impacted.

Lung Cancer Surgery Industry Segmentation

Lung cancer is the lethal lung tumor portrayed by the uncontrolled growth of cells in the lung tissues. The interpretation of lung cancer is confirmed by biopsy, which is carried out using bronchoscopy or CT-guidance. Lung cancer surgery is the surgical ablation of cancer tissue from the lung. The type of surgery depends upon the size of the tumor and its position within the lung.

By Type
Thoracotomy
Lobectomy
Sleeve Resection
Segmentectomy
Pneumonectomy
Minimally Invasive Surgeries
By Product
Surgical Devices
Monitoring Devices
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Lung Cancer Surgery Market Size Summary

The lung cancer surgery market is experiencing growth driven by increasing air pollution and its impact on lung cancer rates. The prevalence of lung cancer is rising, particularly in highly polluted areas like India, where air quality issues contribute significantly to respiratory diseases. Technological advancements in early-stage treatment options are further propelling market expansion. Surgical techniques such as segmentectomy are gaining popularity due to their favorable outcomes, including reduced pain and quicker recovery compared to traditional methods. This technique is particularly beneficial for patients with limited lung capacity, offering higher survival rates and better organ function retention, which is expected to enhance market growth.

In the United States, the lung cancer surgery market is bolstered by a significant number of diagnosed cases and improved survival rates, particularly for non-small cell lung cancer. The demand for cancer treatment is high, driven by the aging population and the burden of the disease. The market is moderately competitive, with major players holding significant shares, yet technological innovations and cost-effective product offerings from mid-size and smaller companies are increasing their market presence. Key players in the market include Accuray Incorporated, GE Healthcare, Johnson and Johnson, Olympus Corporation, and Siemens Healthineers AG, all contributing to the dynamic landscape of the lung cancer surgery market.

Explore More

Lung Cancer Surgery Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Burden of Lung Cancer

      2. 1.2.2 Technological Advancements in the Field of Minimally Invasive Surgeries

      3. 1.2.3 Rise in the Level of Air Pollution

    3. 1.3 Market Restraints

      1. 1.3.1 Effective Alternative Treatment

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Type

      1. 2.1.1 Thoracotomy

        1. 2.1.1.1 Lobectomy

        2. 2.1.1.2 Sleeve Resection

        3. 2.1.1.3 Segmentectomy

        4. 2.1.1.4 Pneumonectomy

      2. 2.1.2 Minimally Invasive Surgeries

    2. 2.2 By Product

      1. 2.2.1 Surgical Devices

      2. 2.2.2 Monitoring Devices

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Lung Cancer Surgery Market Size FAQs

The Lung Cancer Surgery Market is projected to register a CAGR of 7% during the forecast period (2024-2029)

Accuray Incorporated, GE Healthcare, Johnson and Johnson, Olympus Corporation and Siemens Healthineers AG are the major companies operating in the Lung Cancer Surgery Market.

Lung Cancer Surgery Report Snapshots

Lung Cancer Surgery Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)